Addition of Dulaglutide or Empagliflozin to Standard-of-Care Treatment: Effect on Liver Steatosis in Patients With Type 2 Diabetes MellitusEmmanouil Koullias, John Koskinas, Stavros Athanasopoulos et al.|Cureus|2024Cited by 4